信隆健康
(002105)
| 流通市值：26.13亿 | | | 总市值：26.39亿 |
| 流通股本：3.64亿 | | | 总股本：3.68亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 581,572,945.02 | 305,863,965.34 | 1,191,218,072.31 | 818,126,774.64 |
| 营业收入 | 581,572,945.02 | 305,863,965.34 | 1,191,218,072.31 | 818,126,774.64 |
| 二、营业总成本 | 591,599,435.86 | 307,588,082.54 | 1,192,102,116.78 | 817,159,759.69 |
| 营业成本 | 508,307,938.08 | 267,075,097.78 | 1,010,642,456.78 | 686,847,027.3 |
| 税金及附加 | 4,945,199.19 | 2,510,265.37 | 9,068,324.22 | 7,088,142.97 |
| 销售费用 | 19,890,036.68 | 8,939,848.21 | 38,966,008.46 | 25,925,254.39 |
| 管理费用 | 37,323,549.56 | 18,773,398.42 | 90,322,213.82 | 63,910,837.7 |
| 研发费用 | 20,403,095.53 | 10,058,731.28 | 42,242,113.85 | 30,119,353.86 |
| 财务费用 | 729,616.82 | 230,741.48 | 860,999.65 | 3,269,143.47 |
| 其中:利息费用 | 7,839,699.27 | 3,602,353.65 | 15,470,403.51 | 10,765,934.22 |
| 其中:利息收入 | -3,384,467.98 | 1,609,410.37 | 7,770,924.09 | 5,442,197.95 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | -236.8 | - |
| 加:投资收益 | -1,683,644.97 | -917,006.04 | -5,839,080.81 | -3,462,353.23 |
| 资产处置收益 | -184,471.34 | 1,607.21 | 2,537,108 | 2,842,836.65 |
| 资产减值损失(新) | -3,256,876.1 | - | -17,772,593.08 | - |
| 信用减值损失(新) | 553,097.02 | 963,589.66 | -3,892,502.14 | -919,253.3 |
| 其他收益 | 979,165.46 | 519,849.33 | 2,554,340.2 | 2,243,493.56 |
| 四、营业利润 | -13,619,220.77 | -1,156,077.04 | -23,297,009.1 | 1,671,738.63 |
| 加:营业外收入 | 4,991,965.73 | 476,047.59 | 1,987,003.45 | 1,919,401.24 |
| 减:营业外支出 | 2,349,066.43 | 322,614.66 | 1,551,351.3 | 1,350,638.31 |
| 五、利润总额 | -10,976,321.47 | -1,002,644.11 | -22,861,356.95 | 2,240,501.56 |
| 减:所得税费用 | 6,174,845.81 | 1,594,964.84 | -3,335,185.74 | 1,863,480.32 |
| 六、净利润 | -17,151,167.28 | -2,597,608.95 | -19,526,171.21 | 377,021.24 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -17,151,167.28 | -2,597,608.95 | -19,526,171.21 | 377,021.24 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -15,747,197.9 | -2,147,058.11 | -18,933,887.07 | 837,649.51 |
| 少数股东损益 | -1,403,969.38 | -450,550.84 | -592,284.14 | -460,628.27 |
| 扣除非经常损益后的净利润 | -18,488,755.25 | -2,744,476.9 | -23,648,859.9 | -2,887,427.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.04 | -0.01 | -0.05 | 0 |
| (二)稀释每股收益 | -0.04 | -0.01 | -0.05 | 0 |
| 八、其他综合收益 | -5,517,297.11 | -84,596.05 | -4,789,743.94 | -711,846.28 |
| 归属于母公司股东的其他综合收益 | -3,772,228.89 | -63,088.69 | -3,284,110.7 | -452,015.93 |
| 九、综合收益总额 | -22,668,464.39 | -2,682,205 | -24,315,915.15 | -334,825.04 |
| 归属于母公司股东的综合收益总额 | -19,519,426.79 | -2,210,146.8 | -22,217,997.77 | 385,633.58 |
| 归属于少数股东的综合收益总额 | -3,149,037.6 | -472,058.2 | -2,097,917.38 | -720,458.62 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-04-23 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |